Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Exter Neil, Director. Officer active across 1 company, notably Revolution Medicines, Inc.. In total, 5 reports have been recorded. Breakdown: 0 buy · 3 sells. History available since 25 May 2021. The latest transaction was filed on 16 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Neil Exter is a Director at Revolution Medicines, Inc. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for Revolution Medicines.